How dengue virus infections hijack human plasmin
Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope ...
Hosted on MSN2d
AbViro launches NIH-funded dengue challenge trial
The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.
Science Daily10d
Hijacking of plasmin by dengue virus for infection
Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.
Reemergence of dengue serotype 3 may increase severity of outbreaks of the disease in Brazil
The reemergence of dengue virus serotype 3 (DENV-3) in Brazil after 17 years could help worsen fresh outbreaks of the disease ...